QuiVad

Home / Germany / Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

Short position disclosed on May 13, 2025. Bundesanzeiger register read on November 5, 2026.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%
Jan 2026Apr 2026Jul 2026Oct 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 0.50% on May 13, 2025. The shaded band matches the twelve months of the first chart.

May 13, 2025 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Squarepoint Ops LLC0.50%unchangedMay 13, 2025

In the United States KPTI (Nasdaq): 7,266,973 shares sold short on October 15, 2026. FINRA names no fund.

On the other side: the funds that hold Karyopharm Therapeutics Inc Titelia

Follow by RSS

Get the moves on Karyopharm Therapeutics Inc by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

1 disclosure on record for this share.
DateFund% of capitalEnd of publication
May 13, 2025Squarepoint Ops LLC0.50%still open

Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Karyopharm Therapeutics Inc, source Bundesanzeiger, data as at May 13, 2025, https://www.quivad.com/action/karyopharm-therapeutics-inc

Embed the chart

<iframe src="https://www.quivad.com/embed/action/karyopharm-therapeutics-inc" width="600" height="280" title="Karyopharm Therapeutics Inc" loading="lazy" style="border:0"></iframe>

Badge

<a href="https://www.quivad.com/action/karyopharm-therapeutics-inc"><img src="https://www.quivad.com/action/karyopharm-therapeutics-inc/badge.svg" alt="QuiVad, Karyopharm Therapeutics Inc"></a>